Jan 18, 2026
What protocols have been tested to prevent metabolic rebound after stopping GLP‑1 receptor agonists?
Clinical trials and systematic reviews consistently document clinically meaningful metabolic and weight rebound after stopping GLP‑1 receptor agonists, and while commentators and reviews urge “structu...